Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Addus HomeCare Corp EVP and Chief HR Officer Roberton James Stevenson reported a stock grant and a related share sale. On February 20, he acquired 2,858 shares of common stock as a grant, at no cost, which vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and potential acceleration upon a change in control. On February 23, he sold 561 shares at $114.91 per share under a pre-set Rule 10b5-1 plan to cover tax obligations from vesting restricted stock awards, leaving 14,881 shares directly owned.
Addus HomeCare Corp EVP and Chief Development Officer Cliff Donald Blessing reported mixed share activity. He sold 371 shares of common stock in an open-market transaction at $114.91 per share under a pre-set 10b5-1 plan to cover tax obligations. He also received a grant of 2,858 restricted shares that vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Following these transactions, he directly holds 12,888 shares.
Addus HomeCare Corp executive Michael D. Wattenbarger reported both an equity grant and a small share sale. On February 20, 2026, he acquired 3,117 shares of common stock as a grant with no purchase price, lifting his holdings to 10,913 shares.
The granted shares vest in three equal installments on each of February 20, 2027, 2028, and 2029, subject to continued service and change-in-control provisions. On February 23, 2026, he sold 577 shares at $114.91 per share in an open-market trade under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 10,336 directly owned shares.
Addus HomeCare Corp executive David W. Tucker reported both an equity award and a small share sale. On February 20, 2026, he acquired 3,429 shares of common stock as a grant or award at no cost. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and customary change-in-control provisions.
On February 23, 2026, Tucker executed an open-market sale of 658 shares of common stock at $114.91 per share. According to the footnote, this sale was made under a previously established Rule 10b5-1 trading plan adopted on March 13, 2025 and was intended to satisfy tax obligations arising from the vesting of restricted stock awards.
Addus HomeCare Corp executive Darby Anderson reported mixed share activity. On February 20, 2026, he acquired 3,897 shares of common stock as a grant that will vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change‑in‑control provisions.
On February 23, 2026, he sold 666 shares of common stock at $114.91 per share in an open‑market transaction under a previously established Rule 10b5‑1 trading plan adopted on March 5, 2025, to cover tax obligations from vesting restricted stock awards. After these transactions, he held 47,375 shares directly.
Addus HomeCare Corp EVP and Chief Legal Officer Sean Gaffney reported two stock transactions. He received a grant of 3,897 common shares at no cost, vesting in three equal installments on February 20 of 2027, 2028, and 2029. He then executed an open-market sale of 737 shares at $114.91 under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 21,339 directly held shares.
Addus HomeCare Corp Executive Vice President and Chief Financial Officer Brian Poff reported two stock transactions. On February 20, 2026, he acquired 11,431 shares of common stock as a grant that will vest in three equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions.
On February 23, 2026, he sold 1,858 shares of common stock at $114.91 per share in an open-market transaction pursuant to a previously established Rule 10b5-1 trading plan, to cover tax obligations from restricted stock vesting. After the sale, he directly owned 66,553 shares of Addus common stock.
Addus HomeCare Corp reported that President and Chief Operating Officer Heather Brianne Dixon acquired a grant of 12,470 shares of common stock at no cost as equity compensation. These shares vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions. Following this grant, she directly holds a total of 44,659 common shares.
Addus HomeCare Corp Chairman and CEO Allison R. Dirk reported both a stock grant and a tax-related share sale. He received a grant of 28,576 shares of common stock that vest in equal parts on February 20 of 2027, 2028, and 2029. He also sold 4,535 shares at $114.91 per share under a previously established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, and held 190,502 shares afterward.
Addus HomeCare Corporation reported strong growth for the fourth quarter and full year 2025. Fourth quarter net service revenues were $373.1 million, up 25.6% from $297.1 million a year earlier, with net income rising to $29.8 million or $1.61 per diluted share from $19.5 million or $1.07.
Adjusted EBITDA for the quarter increased 33.3% to $50.3 million. For full year 2025, net service revenues grew 23.2% to $1.42 billion, net income reached $95.9 million or $5.22 per diluted share, and adjusted EBITDA was $180.0 million, up from $140.3 million in 2024.
Personal care generated 76.6% of fourth quarter revenue, hospice 18.8%, and home health 4.6%. The company highlighted organic growth in personal care and hospice, state rate increases in Texas and Illinois, year-end cash of $81.6 million, and reduced bank debt of $124.3 million.